Skip to main content

Table 2 Comparison of the hormone parameters between two gender

From: Graves ophthalmopathy a neglected comorbidity of graves’ disease; a detailed investigation and management of sixty-eight patients in a tertiary healthcare center

 

All patients

Female (n = 45)

Male (n = 23)

p

Age (year)

45.4 ± 13.7

47.4 ± 14.5

46.5 ± 13.7

0.341

TSH (0.38–5.33, mIU/L)

0.27 ± 1.3

0.08 ± 0.36

0.43 ± 1.81

0.255

fT3 (2.3–4.2, pg/mL)

10.60 ± 7.44

10.3 ± 6.06

11.3 ± 9.17

0.302

fT4 (0.61–1.12,ng/mL)

2.79 ± 2.06

2.82 ± 1.32

3.06 ± 2.26

0.512

TRAbs (1-1.5, U/L)

12.15 ± 14.34

14.3 ± 14.72

10.56 ± 14.2

0.629

CAS (Score)

0.58 ± 0.89

0.47 ± 0.72

0.77 ± 1.1

0.416

  1. Data is demonstrated as mean standard deviation
  2. CAS: Clinical Activity Score, TSH: Thyroid Stimulating Hormone, fT3: Free T3, fT4: Free T4